Zoetis (ZTS) Stock Overview

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

ZTS Stock Information

Symbol

ZTS

Address

10 Sylvan WayParsippany, NJ 07054United States

Founded

Trading hours

9:30 AM - 4:00 PM ET

Website

https://www.zoetis.com

Country

🇺🇸 United States

Phone Number

973 822 7000

Zoetis (ZTS) Price Chart

Zoetis Overview: Key Details and Summary

Stock data	2023	Change
Price	$196.48	N/A
Market Cap	$90.61B	N/A
Shares Outstanding	461.17M	-1.65%
Employees	13.80K	N/A
Shareholder Equity	4.99B	13.35%

Valuation	2023	Change
P/E Ratio	38.75	N/A
P/S Ratio	10.61	N/A
P/B Ratio	18.15	N/A
P/FCF	55.90	N/A

Dividends	2023	Change
Dividend Yield	0.76%	N/A
Dividend per share	1.5005	N/A
Dividend Payout Ratio	0.2957	N/A

Growth	2023	Change
ROIC	0.2036	N/A
WACC	0.0317	N/A
Return on Equity	0.4688	N/A

Earnings	2023	Change
Revenue	$8.54B	N/A
Earnings	$2.34B	N/A
Free Cash Flow	$1.62B	N/A
EPS	5.07	N/A
Earnings Yield	0.0258	N/A
Gross Margin	0.7003	N/A
Operating Margin	0.3592	N/A
Net income margin	0.2739	N/A
FCF Margin	0.1897	N/A

Financial Strength	2023	Change
Total Assets	$14.29B	N/A
Total Debt	$6.75B	N/A
Cash on Hand	$2.04B	N/A
Debt to Equity	$1.86	-22.07%
Cash to Debt	0.3019	-31.73%
Current Ratio	$3.36	41.68%

Other data	2023	Change
Buyback Yield	0.0121	N/A